CHAPTER 1. INTRODUCTION
1.1.Market Definition
1.2.Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2.Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5.Degree of Competition
3.3.PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. The rise in R&D funding and initiatives
4.1.2. Growing investments in synthetic biology companies
4.1.3. Increasing demand for synthetic genes and synthetic cells
4.2. Market Restraints & Challenges
4.2.1. Standardization of biological parts
4.2.2. Environmental and security issues
4.3. Market Opportunities
4.3.1. Rising demand for protein therapeutics
4.3.2. Increasing concerns related to fuel consumption
CHAPTER 5. GLOBAL SYNTHETIC BIOLOGY MARKET– BY TOOLS AND
TECHNOLOGY
5.1. Tool
5.1.1. Oligonucleotides
5.1.2. Enzymes
5.1.3. Cloning Technology Kits
5.1.4. Chassis Organisms
5.1.5. Xeno-Nucleic Acids
5.2. Technology
5.2.1. Gene Synthesis
5.2.2. Genome Engineering
5.2.3. Cloning and Sequencing
5.2.4. Next-Generation Sequencing
5.2.5. Site-Directed Mutagenesis
5.2.6. Measurement and Modelling
5.2.7. Microfluidics
CHAPTER 6. GLOBAL SYNTHETIC BIOLOGY MARKET – BY PRODUCTS
6.1. Introduction
6.2. Core Products
6.3. Enabling Products
CHAPTER 7. GLOBAL SYNTHETIC BIOLOGY MARKET – BY APPLICATION
7.1. Introduction
7.2. Medical Applications
7.2.1. Pharmaceuticals
7.2.2. Drug Discovery and Therapeutics
7.2.3. Artificial Tissue and Tissue Regeneration
7.3. Industrial Applications
7.3.1. Biofuel and Renewable Energy
7.3.2. Biomaterials and Green Chemicals
7.3.3. Industrial Enzymes
7.4. Food and Agriculture
7.5. Environmental Applications
7.5.1. Bioremediation
7.5.2. Biosensing
CHAPTER 8. GLOBAL SYNTHETIC BIOLOGY MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL SYNTHETIC BIOLOGY MARKET - COMPANY PROFILES
9.1. Twist Bioscience
9.2. Integrated DNA Technologies (IDT)
9.3. Agilent Technologies
9.4. Intrexon Corporation
9.5. Thermo Fisher Scientific
9.6. Amyris, Inc.
9.7. Genscript Biotech Corporation
9.8. GinkgoBioworks
9.9. Merck KGaA
9.10. New England Biolabs (NEB)
9.11. Synthetic Genomics
9.12. Novozymes
9.13. Gevo, Inc.
9.14. OriGene Technologies, Inc.
9.15. REG Life Sciences, LLC
CHAPTER 10. GLOBAL SYNTHETIC BIOLOGY MARKET - COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3.Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
